Both in Pharmaceuticals
Liquidia vs Arcutis Biotherapeutics
Over the past year LQDA returned +69.8% and ARQT returned +41.8%; their daily moves had a correlation of 0.17.
LQDA +69.8% ARQT +41.8%Growth of $1, one year, split-adjusted
| Metric | LQDA | ARQT |
|---|---|---|
| Price | $47.38 | $34.05 |
| Market cap | $4.24B | $4.28B |
| Today | +12.27% | +6.41% |
| 1 month | +82.9% | +42.3% |
| 6 months | +12.4% | +40.9% |
| Year to date | +37.4% | +17.3% |
| 1 year | +87.9% | +37.5% |
| Revenue growth (YoY) | +1842.7% | +59.3% |
| Gross margin | 93.3% | 91.6% |
| Net margin | 43.5% | 11.6% |
| P/E (TTM) | 30.6× | 150.1× |
| Price / sales | 9.4× | 9.2× |
| Net cash | $108.1M | $129.7M |
| Dividend yield | — | — |
| Volatility (60d) | 191.5% | 54.8% |
| Short % of float | 26.2% | 18.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).